Keating Investment Counselors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5,880
| Closed | -$301K | – | 85 |
|
|
2022
Q4 | $301K | Buy |
+5,880
| New | +$282K | 0.12% | 73 |
|
|
2021
Q2 | – | Sell |
-6,214
| Closed | -$225K | – | 62 |
|
|
2021
Q1 | $225K | Sell |
6,214
-1,500
| -19% | -$53.3K | 0.11% | 57 |
|
|
2020
Q4 | $284K | Sell |
7,714
-417
| -5% | -$15.3K | 0.14% | 54 |
|
|
2020
Q3 | $283K | Hold |
8,131
| – | – | 0.15% | 52 |
|
|
2020
Q2 | $252K | Sell |
8,131
-316
| -4% | -$10.7K | 0.14% | 53 |
|
|
2020
Q1 | $262K | Sell |
8,447
-3,373
| -29% | -$115K | 0.16% | 57 |
|
|
2019
Q4 | $439K | Hold |
11,820
| – | – | 0.19% | 54 |
|
|
2019
Q3 | $403K | Sell |
11,820
-3,162
| -21% | -$115K | 0.18% | 53 |
|
|
2019
Q2 | $616K | Sell |
14,982
-1,159
| -7% | -$46K | 0.27% | 50 |
|
|
2019
Q1 | $650K | Sell |
16,141
-606
| -4% | -$24.3K | 0.29% | 51 |
|
|
2018
Q4 | $694K | Hold |
16,747
| – | – | 0.35% | 46 |
|
|
2018
Q3 | $700K | Hold |
16,747
| – | – | 0.3% | 47 |
|
|
2018
Q2 | $576K | Sell |
16,747
-1,014
| -6% | -$34.7K | 0.27% | 48 |
|
|
2018
Q1 | $598K | Hold |
17,761
| – | – | 0.28% | 45 |
|
|
2017
Q4 | $610K | Buy |
17,761
+1
| +0% | +$34 | 0.26% | 48 |
|
|
2017
Q3 | $602K | Sell |
17,760
-422
| -2% | -$13.6K | 0.26% | 48 |
|
|
2017
Q2 | $579K | Hold |
18,182
| – | – | 0.25% | 47 |
|
|
2017
Q1 | $590K | Sell |
18,182
-2,673
| -13% | -$84.3K | 0.26% | 45 |
|
|
2016
Q4 | $643K | Hold |
20,855
| – | – | 0.3% | 43 |
|
|
2016
Q3 | $670K | Sell |
20,855
-2,530
| -11% | -$84.6K | 0.33% | 42 |
|
|
2016
Q2 | $781K | Sell |
23,385
-23,413
| -50% | -$747K | 0.38% | 42 |
|
|
2016
Q1 | $1.32M | Buy |
46,798
+30,039
| +179% | +$858K | 0.64% | 39 |
|
|
2015
Q4 | $513K | Sell |
16,759
-1,264
| -7% | -$39.8K | 0.26% | 44 |
|
|
2015
Q3 | $537K | Hold |
18,023
| – | – | 0.29% | 45 |
|
|
2015
Q2 | $573K | Hold |
18,023
| – | – | 0.29% | 45 |
|
|
2015
Q1 | $595K | Hold |
18,023
| – | – | 0.3% | 45 |
|
|
2014
Q4 | $533K | Hold |
18,023
| – | – | 0.27% | 48 |
|
|
2014
Q3 | $506K | Hold |
18,023
| – | – | 0.26% | 47 |
|
|
2014
Q2 | $508K | Hold |
18,023
| – | – | 0.24% | 48 |
|
|
2014
Q1 | $549K | Hold |
18,023
| – | – | 0.27% | 47 |
|
|
2013
Q4 | $524K | Hold |
18,023
| – | – | 0.27% | 45 |
|
|
2013
Q3 | $491K | Hold |
18,023
| – | – | 0.27% | 45 |
|
|
2013
Q2 | $479K | Buy |
+18,023
| New | +$498K | 0.27% | 46 |
|
Other funds holding PFE
Keating Investment Counselors's PFE Position: Q1 2023 in Review
Keating Investment Counselors sold out of Pfizer (PFE) in Q1 2023, closing a stake of 5,880 shares — an estimated $301K sold.
Keating Investment Counselors first reported a position in PFE in Q2 2013 and held it in 33 quarters. The position peaked at $1.32M in Q1 2016. 3,103 funds tracked by Wall St. Rank hold PFE as of Q1 2023.
- Keating Investment Counselors reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
- Keating Investment Counselors sold 5,880 Pfizer shares in Q1 2023, an estimated $301K.
- Keating Investment Counselors first reported a position in Pfizer in Q2 2013 and held it in 33 quarters.
- Keating Investment Counselors's Pfizer position peaked at $1.32M in Q1 2016.
- 3,103 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.
Based on Keating Investment Counselors's 13F filing for Q1 2023, filed 4 May 2023.